Characterization of membrane surface proteins of Mycoplasma agalactiae during natural infection

S Tola1, D Manunta, M Cocco

  • 1Istituto Zooprofilattico Sperbnentale della Sardegna G Pegreffi, Sassari, Italy.

Insights

Mycoplasma agalactiae antigenic variation was studied. Thirty-day sheep sera recognized all surface proteins, inhibiting mycoplasma growth, with only the 35 kDa protein recognized by eluted antibodies after trypsin digestion.

Area of Science:

  • Veterinary Microbiology
  • Immunology
  • Molecular Biology

Background:

  • Mycoplasma agalactiae causes contagious agalactia, a significant disease in small ruminants.
  • Antigenic variation in M. agalactiae complicates vaccine development and disease control.
  • Understanding surface protein immunogenicity is crucial for targeted interventions.

Purpose of the Study:

  • To analyze the antigenic variation of seven Mycoplasma agalactiae wild strains.
  • To identify specific sera capable of recognizing and inhibiting mycoplasma growth.
  • To investigate the immunogenicity and antibody recognition of M. agalactiae surface proteins.

Main Methods:

  • Analysis of antigenic variation using sera from naturally infected sheep.
  • Growth inhibition assays with different sera.
  • Trypsin digestion of surface proteins (55 kDa and 35 kDa) at 500 µg/ml.
  • Immunoprecipitation and antibody elution studies.

Main Results:

  • Sera collected 30 days post-infection recognized all analyzed surface proteins.
  • These 30-day sera demonstrated mycoplasmacidal activity, inhibiting bacterial growth.
  • Two highly immunogenic proteins (55 kDa and 35 kDa) were identified and susceptible to trypsin digestion.
  • While both proteins were immunoprecipitated, only the 35 kDa protein was recognized by eluted antibodies.

Conclusions:

  • Specific antibody responses in sheep sera evolve over time, with 30-day sera showing broad recognition of M. agalactiae surface antigens.
  • The 35 kDa surface protein is a key target for specific antibody recognition following infection.
  • Findings provide insights into M. agalactiae antigenic variation and potential targets for diagnostic or vaccine strategies.